IGF::OT::IGF SBIR PHASE I TOPIC 352 CELL-BASED MODELS FOR PROSTATE CANCER HEALTH DISPARITY RESEARCH
IGF::OT::IGF SBIR PHASE I TOPIC 352 CELL-BASED MODELS FOR PROSTATE CANCER HEALTH DISPARITY RESEARCH
批准号:
9357341
负责人:
JOHNG RHIM
金额:
$22.47万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-19 至 2017-06-18
关键词:
African AmericanBiologicalBiological FactorsBiopsy SpecimenCancer cell lineCellsCulture MediaDeath RateEnvironmental ExposureEpithelialEpithelial CellsHigh-Risk CancerIn VitroInstitutional Review BoardsMalignant NeoplasmsMalignant neoplasm of prostateMarketingModelingPhaseProcessProstateProstatic NeoplasmsProtocols documentationReagentResearchSmall Business Innovation Research GrantTissue BanksTissuesWritingbasecancer health disparitycaucasian Americanhigh risk menin vivo Modelmenpopulation basedprostate cancer cell linepublic-private partnershipsocioeconomics
中文摘要
前列腺癌的健康差异研究表明,非裔美国人(AA)男性在
英文摘要
Prostate cancer health disparities studies have shown that African-American (AA) men are at
higher risk for developing prostate cancer, as well as at higher risk of cancer specific death rates
as compared to Caucasian American (CA) men. The causes of disparities have been attributed
to socioeconomic differences, environmental exposures and biological factors. Most disparities
studies have been population based, in part, due to the lack of relevant in vitro and in vivo models
to support biological studies. In this Phase I proposal, we will develop an annotated AA prostate
epithelial cancer cell line with donor matched normal prostate epithelial cells and bio-banked
reference prostate tissues. To support the feasibility of establishing 50 prostate cancer cell lines
from AA men in a subsequent Phase II application, we will prepare written protocols for tissue
collection, processing, establishment of conditionally reprogrammed cells and the reagents
necessary for performing studies with these cells. We will determine the commercial feasibility
for cell distribution and reagent marketing through a private-public partnership.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金